1. Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma
   Shui-Qing Bi et al, 2022, Frontiers in Oncology CrossRef
2. Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma
   Mohit Arora et al, 2020, Frontiers in Oncology CrossRef
3. Correlation of Diffusion Tensor Imaging Parameters with the Pathological Grade of Brain Glioma and Expression of Vascular Endothelial Growth Factor and Ki-67
   Jing Wu et al, 2022, Iranian Journal of Radiology CrossRef